Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

EZCORP, Inc. - Class A Non-Voting Common Stock (NQ:EZPW)

13.50 -0.75 (-5.26%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about EZCORP, Inc. - Class A Non-Voting Common Stock

< Previous 1 2 3 4 Next >
Recap: EZCORP Q1 Earnings
 
Via Benzinga
EZCORP to Release First Quarter Fiscal 2024 Results After Market Close on Wednesday, January 31, 2024
From EZCORP, Inc.
Via Business Wire
EZCORP Reports Fourth Quarter and Full Year Fiscal 2023 Results
From EZCORP, Inc.
Via Business Wire
Earnings Preview For EZCORP
 
Via Benzinga
EZCORP, Inc. to Participate in the Stephens Annual Investor Conference
From EZCORP, Inc.
Via Business Wire
Earnings Outlook For EZCORP
 
Via Benzinga
Recap: EZCORP Q2 Earnings
 
Via Benzinga
EZCORP Earnings Preview
 
Via Benzinga
Earnings Scheduled For January 31, 2024
Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion. 
Via Benzinga
A Preview Of EZCORP's Earnings
 
Via Benzinga
Recap: EZCORP Q4 Earnings
 
Via Benzinga
EZCORP, Inc. to Release Fourth Quarter and Full Year Fiscal 2023 Results After Market Close on Wednesday, November 15, 2023
From EZCORP, Inc.
Via Business Wire
Payday Lenders Challenge Financial Consumer Watchdog's Budget Structure In Supreme Court: What It Means For Your Wallet
 
Via Benzinga
3 Stocks That Could Soar From the Rise in Paycheck-to-Paycheck Living
With consumers struggling against stubborn headwinds, these stocks for paycheck-to-paycheck living may enjoy cynical relevance. 
Via InvestorPlace
EZCORP Reports Third Quarter Fiscal 2023 Results
From EZCORP, Inc.
Via Business Wire
EZCORP's Return On Capital Employed Overview
 
Via Benzinga
EZCORP, Inc. to Release Third Quarter Results After Market Close on Wednesday, August 2, 2023
From EZCORP, Inc.
Via Business Wire
Short Interest Sector Focus: Financial Services Sector
As of the close of business on Tuesday, 6/6, we captured the Top 10 Highest Short Interest % stocks within the Financial Services sector. The average short interest for stocks within the Financial... 
Via Benzinga
EZCORP to Participate in June Conferences
From EZCORP, Inc.
Via Business Wire
7 Stocks to Sell if the Fed Keeps Raising Interest Rates
If the Federal Reserve decides to get really serious with interest rates, these would be the stocks to sell. 
Via InvestorPlace
EZCORP Reports Second Quarter Fiscal 2023 Results
From EZCORP, Inc.
Via Business Wire
EZCORP, Inc. to Release Second Quarter Results After Market Close on Wednesday, May 3, 2023
From EZCORP, Inc.
Via Business Wire
Short Interest Sector Focus: Financial Services Sector
As of the close of business on Monday, 4/24, we captured the Top 10 Highest Short Interest % stocks within the Financial Services sector. The average short interest for stocks within the Financial... 
Via Benzinga
7 Smart Stocks to Buy When Interest Rates Rise
Although market fears have many investors concerned, these stocks to buy when interest rates rise may offer shelter from the storm. 
Via InvestorPlace
EZCORP Reports First Quarter Fiscal 2023 Results
From EZCORP, Inc.
Via Business Wire
EZCORP, Inc. to Release First Quarter Results After Market Close on Wednesday, February 1, 2023
From EZCORP, Inc.
Via Business Wire
EZCORP Announces Upsize and Pricing of Private Offering of $200,000,000 of Convertible Senior Notes Due 2029
From EZCORP, Inc.
Via Business Wire
Earnings Scheduled For February 1, 2023
Companies Reporting Before The Bell • Novo Nordisk (NYSE:NVO) is expected to report quarterly earnings at $0.85 per share on revenue of $6.84 billion. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 4, 2023
 
Via Benzinga
Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session
Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.